Deferasirox
| Deferasirox | |
|---|---|
| Term | Deferasirox |
| Short definition | Deferasirox - (pronounced) (deh-FER-a-ser-ox) A drug used to treat excess iron in the blood caused by blood transfusions. It is being studied for the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not produce enough healthy blood cells) and other conditions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Deferasirox - (pronounced) (deh-FER-a-ser-ox) A drug used to treat excess iron in the blood caused by blood transfusions. It is being studied for the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not produce enough healthy blood cells) and other conditions. Deferasirox binds to extra iron in the blood. The drug and iron are eliminated from the body in the urine. It's a kind of chelating agent. Also called exjade
External links
- Medical encyclopedia article on Deferasirox
- Wikipedia's article - Deferasirox
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski